13 Oct, 2026
An early advocate for the theory that the Covid-19 virus was engineered in and leaked from a lab in China is no longer the leading choice to be America’s top…
Americans have more trust in science than most of the rest of the world, according to a new survey of people in 140 countries, a finding that may seem difficult…
This story has been updated. The Trump administration announced Thursday that it is investigating nine universities for alleged fraud related to visas commonly used by postdoctoral researchers, a core part…
Welcome to the debut of ID Consult, a new STAT column from infectious disease physician Krutika Kuppalli about diseases, outbreak response, global health, and health policy. A 28-year-old laboratory worker…
President Donald Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time, to more than 20 million seniors, giving them $90 each…

Medicare is in desperate need of DOGE deregulation

Lost amid the turmoil of DOGE’s federal workforce cuts was a mid-February executive order directing DOGE to repeal regulations that impede innovation, are overly burdensome, or not clearly authorized by statute. Now it appears that DOGE and the Trump administration are taking action on that order. The administration has even created a website, regulations.gov, where […]

4 mins read

Women’s Health Initiative to receive NIH funding after all

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. On Monday, the groundbreaking Women’s Health Initiative announced that the federal contracts funding the study’s 40 regional centers would end with the fiscal year. But on Thursday a federal official said the Department of Health and Human Services was reversing […]

1 min read

Bristol’s Cobenfy disappoints as supplemental antipsychotic drug

A landmark new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of standard-of-care therapy, Bristol Myers Squibb announced Tuesday. The drug, Cobenfy, was approved last year based on data from three randomized studies comparing the drug to placebo. It was the first new mechanism-of-action approved for schizophrenia in decades. Doctors […]

1 min read